We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $87.6B
1-Year Est. Return 131.08%
This Fund
S&P 500
This Quarter Est. Return
+14.05%
1 Year Est. Return
+131.08%
3 Year Est. Return
+497.29%
5 Year Est. Return
+787.25%
10 Year Est. Return
AUM
$2.24B
AUM Growth
-$1.58B
Cap. Flow
-$1.51B
Cap. Flow %
-67.51%
Top 10 Hldgs %
84.8%
Holding
749
New
274
Increased
80
Reduced
75
Closed
315

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$53.2M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$22.8M
3
AMZN icon
Amazon
AMZN
+$3.46M
4
URNM icon
Sprott Uranium Miners ETF
URNM
+$3.06M
5
XONE
The ExOne Company
XONE
+$2.47M

Sector Composition

Rank Sector Weight
1 Technology 5.4%
2 Consumer Discretionary 0.75%
3 Healthcare 0.26%
4 Energy 0.24%
5 Industrials 0.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OVV icon
576
CALL
Ovintiv
OVV
$17.3B
-7,900
Closed -$311K
OXY icon
577
CALL
Occidental Petroleum
OXY
$56.8B
-13,200
Closed -$435K
PAVM icon
578
CALL
PAVmed
PAVM
$35.4M
-28
Closed -$77K
PAVM icon
579
PAVmed
PAVM
$35.4M
-5
Closed -$15K
PFE icon
580
CALL
Pfizer
PFE
$143B
-21,700
Closed -$897K
PLBY icon
581
CALL
Playboy Inc
PLBY
$128M
-1,500
Closed -$37K
PPH icon
582
PUT
VanEck Pharmaceutical ETF
PPH
$959M
-14,200
Closed -$1.03M
PR
583
Permian Resources
PR
$17.8B
-16,120
Closed -$109K
PTGX icon
584
PUT
Protagonist Therapeutics
PTGX
$8.79B
-300
Closed -$9K
PXLW icon
585
CALL
Pixelworks
PXLW
$38.2M
-2,908
Closed -$153K
QNCX icon
586
CALL
Quince Therapeutics
QNCX
$22.9M
-114
Closed -$1.34M
QNCX icon
587
PUT
Quince Therapeutics
QNCX
$22.9M
-149
Closed -$1.75M
RBLX icon
588
CALL
Roblox
RBLX
$25.4B
-4,600
Closed -$358K
RBLX icon
589
Roblox
RBLX
$25.4B
-1,321
Closed -$103K
RDHL
590
CALL
Redhill Biopharma
RDHL
$3.95M
-15
Closed -$72K
RDHL
591
Redhill Biopharma
RDHL
$3.95M
-1
Closed -$4K
RDW icon
592
Redwire
RDW
$2.06B
-70,999
Closed -$753K
REFR icon
593
CALL
Research Frontiers
REFR
$14M
-31,000
Closed -$73K
REKR icon
594
Rekor Systems
REKR
$85.8M
-84,136
Closed -$1.03M
RFL icon
595
CALL
Rafael Holdings
RFL
$101M
-8,213
Closed -$253K
RFL icon
596
PUT
Rafael Holdings
RFL
$101M
-5,577
Closed -$172K
RLMD icon
597
Relmada Therapeutics
RLMD
$557M
-10,699
Closed -$247K
RLX icon
598
PUT
RLX Technology
RLX
$2.47B
-24,900
Closed -$147K
ROOT icon
599
Root
ROOT
$857M
-892
Closed -$80K
RVMD icon
600
CALL
Revolution Medicines
RVMD
$39.9B
-7,800
Closed -$218K

Similar funds

Belvedere Trading's Q4 2021 Portfolio in Review

As of Q4 2021, Belvedere Trading held 749 positions worth $2.24B, down 41% from $3.82B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Belvedere Trading withdrew a net $1.51B in Q4 2021, closing 315 positions and reducing 75 holdings. Its most notable exit was Sprott Uranium Miners ETF, an estimated $3.06M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.4% of assets, up from 4.2% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Belvedere Trading opened a new position in SPDR Gold Trust worth $20.8M.

  • Belvedere Trading's largest Q4 2021 buy was SPDR Gold Trust: 121,631 shares worth $20.8M.
  • Belvedere Trading added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $116M increase.
  • Belvedere Trading's biggest Q4 2021 reduction was Apple, cutting an estimated $53.2M.
  • Belvedere Trading fully exited Sprott Uranium Miners ETF in Q4 2021, selling an estimated $3.06M.
  • Belvedere Trading's ten largest holdings make up 85% of its $2.24B portfolio in Q4 2021.
  • Belvedere Trading opened 274 new positions and closed 315 in Q4 2021.
  • Belvedere Trading's portfolio value fell 41% quarter-over-quarter to $2.24B.

Based on Belvedere Trading's 13F filing for Q4 2021, filed 25 Jan 2022.